Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins

Journal of Virology

Volumn 80, Issue 17, 2006, Pages 8763-8777

  Perdiguero, Beatriz ^a,b   Blasco, Rafael ^a  

^a INIA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN A33; VIRUS ENVELOPE PROTEIN A36; VIRUS ENVELOPE PROTEIN B5; VIRUS ENVELOPE PROTEIN F12; VIRUS ENVELOPE PROTEIN F13; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CYTOPLASM; EXTRACELLULAR SPACE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS PLAQUE; VIRUS RECOMBINANT;

ANIMALS; CELL LINE; CRICETINAE; GENE EXPRESSION REGULATION, VIRAL; GLYCOPROTEINS; HUMANS; IMMUNOPRECIPITATION; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MUTATION; TRANSFECTION; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS ASSEMBLY;

VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33748671566     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00598-06     Document Type: Article

References (46)

1. Blasco, R., and B. Moss. 1991. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65:5910-5920.
2. Blasco, R., and B. Moss. 1992. Role of cell-associated enveloped vaccinia virus in cell-to-cell virus spread. J. Viral. 66:4170-4179.
3. Blasco, R., and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
4. Blasco, R., J. R. Sisler, and B. Moss. 1993. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Viral. 67:3319-3325.
5. Borrego, B., M. M. Lorenzo, and R. Blasco. 1999. Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively. J. Gen. Viral. 80:425-432.
6. Boulter, E. A., and G. Appleyard. 1973. Differences between extracellular and intracellular forms of poxvirus and their implications. Prog. Med. Virol. 16:86-108.
7. Duncan, S. A., and G. L. Smith. 1992. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66:1610-1621.
8. Earl, P. L., and B. Moss. 1991. Expression of proteins in mammalian cells using vaccinia viral vectors, p. 16.15.1-16.18.10. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N. Y.
9. Engelstad, M., S. T. Howard, and G. L. Smith. 1992. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801-810.
10. Frischknecht, F., V. Moreau, S. Rottger, S. Gonfloni, I. Reckmann, G. Superti-Furga, and M. Way. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926-929.
11. Geada, M. M., I. Galindo, M. M. Lorenzo, B. Perdiguero, and R. Blasco. 2001. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J. Gen. Virol. 82:2747-2760.
12. Herrera, E., M. del Mar Lorenzo, R. Blasco, and S. N. Isaacs. 1998. Functional analysis of vaccinia virus BSR protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J. Virol. 72:294-302.
13. 2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release. J. Virol. 39:903-913.
14. Hirt, P., G. Hiller, and R. Wittek. 1986. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J. Virol. 58:757-764.
15. Husain, M., and B. Moss. 2001. Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the BSR envelope glycoprotein in post-Golgi vesicles. J. Virol. 75:7528-7542.
16. Isaacs, S. N., E. J. Wolffe, L. G. Payne, and B. Moss. 1992. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66:7217-7224.
17. Katz, E., B. M. Ward, A. S. Weisberg, and B. Moss. 2003. Mutations in the vaccinia virus A33R and BSR envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. J. Virol. 77:12266-12275.
18. Katz, E., E. Wolffe, and B. Moss. 2002. Identification of second-site mutations that enhance release and spread of vaccinia virus. J. Virol. 76:11637-11644.
19. Katz, E., E. J. Wolffe, and B. Moss. 1997. The cytoplasmic and transmembrane domains of the vaccinia virus BSR protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. J. Virol. 71:3178-3187.
20. Krauss, O., R. Hollinshead, M. Hollinshead, and G. L. Smith. 2002. An investigation of incorporation of cellular antigens into vaccinia virus particles. J. Gen. Virol. 83:2347-2359.
21. Lorenzo, M. M., I. Galindo, G. Griffiths, and R. Blasco. 2000. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon. J. Virol. 74:10535-10550.
22. Lorenzo, M. M., E. Herrera, R. Blasco, and S. N. Isaacs. 1998. Functional analysis of vaccinia virus BSR protein: role of the cytoplasmic tail. Virology 252:450-457.
23. Mathew, E. C., C. M. Sanderson, R. Hollinshead, and G. L. Smith. 2001. A mutational analysis of the vaccinia virus BSR protein. J. Gen. Virol. 82:1199-1213.
24. Moss, B. 1996. Poxviridae: the viruses and their replication, p. 2637-2671. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
25. Newsome, T. P., N. Scaplehorn, and M. Way. 2004. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306:124-129.
26. Parkinson, J. E., and G. L. Smith. 1994. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204:376-390.
27. Payne, L. G. 1992. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation. Virology 187:251-260.
28. Payne, L. G. 1980. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 50:89-100.
29. Roper, R. L., L. G. Payne, and B. Moss. 1996. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:3753-3762.
30. Roper, R. L., E. J. Wolffe, A. Weisberg, and B. Moss. 1998. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72:4192-4204.
31. Rottger, S., F. Frischknecht, I. Reckmann, G. L. Smith, and M. Way. 1999. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:2863-2875.
32. Sanchez-Puig, J. M., and R. Blasco. 2000. Puromycin resistance (pac) gene as a selectable marker in vaccinia virus. Gene 257:57-65.
33. Scaplehorn, N., A. Holmstrom, V. Moreau, F. Frischknecht, I. Reckmann, and M. Way. 2002. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 12:740-745.
34. Schmelz, M., B. Sodeik, M. Ericsson, E. J. Wolffe, H. Shida, G. Miller, and G. Griffiths. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:130-147.
35. Shida, H. 1986. Variants of vaccinia virus hemagglutinin altered in intracellular transport. Mol. Cell. Biol. 6:3734-3745.
36. Smith, G. L., and A. Vanderplasschen. 1998. Extracellular enveloped vaccinia virus. Entry, egress, and evasion. Adv. Exp. Med. Biol. 440:395-414.
37. Smith, G. L., A. Vanderplasschen, and M. Law. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
38. Tooze, J., M. Hollinshead, B. Reis, K. Radsak, and H. Kern. 1993. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:163-178.
39. van Eijl, H., M. Hollinshead, G. Rodger, W. H. Zhang, and G. L. Smith. 2002. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 83:195-207.
40. van Eijl, H., M. Hollinshead, and G. L. Smith. 2000. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271:26-36.
41. Ward, B. M., and B. Moss. 2000. Golgi network targeting and plasma membrane internalization signals in vaccinia virus BSR envelope protein. J. Viral. 74:3771-3780.
42. Ward, B. M., and B. Moss. 2004. Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. J. Virol. 78:2486-2493.
43. Ward, B. M., A. S. Weisberg, and B. Moss. 2003. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 77:4113-4126.
44. Wolffe, E. J., S. N. Isaacs, and B. Moss. 1993. Deletion of the vaccinia virus BSR gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67:4732-4741. (Erratum, 67:5709-5711.)
45. Wolffe, E. J., A. S. Weisberg, and B. Moss. 2001. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 75:303-310.
46. Zhang, W. H., D. Wilcock, and G. L. Smith. 2000. Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J. Virol. 74:11654-11662.